| | About DSEC "Great discoveries and improvements invariably involve the cooperation of many minds.”
- Alexander Graham Bell, Inventor (1847-1922)
The Drug Safety Executive Council (DSEC) is a peer-to-peer membership of drug safety leaders with the common objective of advancing the development of better and safer medicines worldwide. Membership in DSEC is limited to leaders representing companies who develop small and large molecule pharmaceuticals only
DSEC is driven by an esteemed Advisory Board.of industry executives representing many of the largest and most prominent biopharmaceutical companies in the world. A small sample of the topics and issues on our agenda include:
- The Importance of the Critical Path Initiative
- Innovative Medicines Initiative and NIH Roadmap
- Fast-breaking safety matters such as TeGenero (TGN1412)
- The Potential Emergence of China and India as Venues for GLP Quality Safety Testing
- Safety Risk Management Strategies
- Risk Management Planning
- Utility and Application of Knowledge Generation Tools and Intelligence Networks
- Safety Decision-making Processes and Practices
About DSEC Membership
Regular membership in the Drug Safety Executive Council is free and limited to employees of biopharmaceutical companies. A corporate email address is required. Membership benefits include access to:
- Member-only webinars (view our calendar of events)
- Member-only, virtual roundtables via web conference
- Face-to-face roundtables and meetings
- Exclusive access to secure website
- Facilitated member-only online discussion forums
- Member-only, online polls and surveys
- Article exchanges
- Discounts on selected industry wide conferences
- Discounts on selected industry reports
- Discounts on selected benchmarking studies and projects
Join DSEC now. (regular membership is complimentary) Questions regarding DSEC please contact us. We are prepared to respond to email and phone inquiries promptly. |